It was stated earlier that discussions are under way with Pharma to licence the diabetic specific test with an anticipated
return of $5m to $10m annually! Considering the market cap of $13m and say $7.5m annual earnings possible and with a p/e
of 20 for a bio could reach $150m, say $130m giving a ten bagger! I would settle for a 10% dividend at first and leave the market decide.
It was stated earlier that discussions are under way with Pharma...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.42M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $187.1K | 634.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 81754 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 15.57pm 27/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |